Targeted ultra-deep sequencing of a South African Bantu-speaking cohort to comprehensively map and characterize common and novel variants in 65 pharmacologically-related genes.

ABSTRACT:

Background

African populations are characterised by high genetic diversity, which provides opportunities for discovering and elucidating novel variants of clinical importance, especially those affecting therapeutic outcome. Significantly more knowledge is however needed before such populations can take full advantage of the advances in precision medicine. Coupled with the need to concisely map and better understand the pharmacological implications of genetic diversity in populations of sub-Sharan African ancestry, the aim of this study was to identify and characterize known and novel variants present within 65 important absorption, distribution, metabolism and excretion genes.

Patients and methods

Targeted ultra-deep next-generation sequencing was used to screen a cohort of

SUBMITTER: Tshabalala S 

PROVIDER: S-EPMC6675649 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature